Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective The Schizophrenia Cognition Rating Scale (SCoRS) is an interview-based assessment tool for evaluating the cognitive deficit and daily functioning of patients with schizophrenia.Methods Sixty-eight patients with schizophrenia and 68 age- and sex-matched healthy individuals were recruited to validate the Chinese version of SCoRS in this study. All participants underwent cognitive assessment using the SCoRS, which was verified by the Brief Assessment of Cognition in Schizophrenia (BACS), and the UCSD Performance-based Skills Assessment, Brief Version (UPSA-B). Patients with schizophrenia were additionally assessed using the Positive and Negative Syndrome Scale (PANSS).Results SCoRS ratings reported by patients (SCoRS-S), those reported by the interviewer (SCoRS-I), and SCoRS global scores (SCoRS-G) showed significant correlation with all subscales of the BACS and the UPSA-B. On receiver operating characteristic curve analysis, SCoRS-S, SCoRS-I, and SCoRS-G significantly differentiated patients with schizophrenia from healthy controls. Moreover, SCoRS-S and SCoRS-I ratings showed positive correlation with the negative symptoms and general symptoms of PANSS.Conclusion The Chinese version of SCoRS showed good discriminant, concurrent, and external validity, suggesting that it is a useful and convenient tool for assessment of cognitive function among Mandarin-speaking patients with schizophrenia in clinical practice.
Abstract
Objective The Schizophrenia Cognition Rating Scale (SCoRS) is an interview-based assessment tool for evaluating the cognitive deficit and daily functioning of patients with schizophrenia.Methods Sixty-eight patients with schizophrenia and 68 age- and sex-matched healthy individuals were recruited to validate the Chinese version of SCoRS in this study. All participants underwent cognitive assessment using the SCoRS, which was verified by the Brief Assessment of Cognition in Schizophrenia (BACS), and the UCSD Performance-based Skills Assessment, Brief Version (UPSA-B). Patients with schizophrenia were additionally assessed using the Positive and Negative Syndrome Scale (PANSS).Results SCoRS ratings reported by patients (SCoRS-S), those reported by the interviewer (SCoRS-I), and SCoRS global scores (SCoRS-G) showed significant correlation with all subscales of the BACS and the UPSA-B. On receiver operating characteristic curve analysis, SCoRS-S, SCoRS-I, and SCoRS-G significantly differentiated patients with schizophrenia from healthy controls. Moreover, SCoRS-S and SCoRS-I ratings showed positive correlation with the negative symptoms and general symptoms of PANSS.Conclusion The Chinese version of SCoRS showed good discriminant, concurrent, and external validity, suggesting that it is a useful and convenient tool for assessment of cognitive function among Mandarin-speaking patients with schizophrenia in clinical practice.
참고문헌 (35)
- Owen MJ, "Schizophrenia", Lancet, 388, pp.86~97 (2016)
- Cruz BF, "How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS", Cogn Neuropsychiatry, 18, pp.243~251 (2013)
- Mohamed S, "Relationship of cognition and psychopathology to functional impairment in schizophrenia", Am J Psychiatry, 165, pp.978~987 (2008)
- Nuechterlein KH, "The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity", Am J Psychiatry, 165, pp.203~213 (2008)
- Green MF, "Functional co-primary measures for clinical trials in schizophrenia:results from the MATRICS psychometric and standardization study", Am J Psychiatry, 165, pp.221~228 (2008)
- Keefe RS, "The schizophrenia cognition rating scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity", Am J Psychiatry, 163, pp.426~432 (2006)
- Chia MY, "The schizophrenia cognition rating scale: validation of an interview-based assessment of cognitive functioning in Asian patients with schizophrenia", Psychiatry Res, 178, pp.33~38 (2010)
- Green MF, "Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia", Am J Psychiatry, 168, pp.400~407 (2011)
- Harvey PD, "Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone", Schizophr Res, 127, pp.188~194 (2011)
- Harvey PD, "Comprehensive review of the research employing the schizophrenia cognition rating scale (SCoRS)", Schizophr Res, 210, pp.30~38 (2019)
- Keefe RS, "Reliability, validity and treatment sensitivity of the schizophrenia cognition rating scale", Eur Neuropsychopharmacol, 25, pp.176~184 (2015)
- Vita A, "Interviewbased assessment of cognition in schizophrenia: applicability of the schizophrenia cognition rating scale (SCoRS) in different phases of illness and settings of care", Schizophr Res, 146, pp.217~223 (2013)
- Jeon Dong-Wook, "Correlation between Performance-Based and Interview-Based Cognitive Measurements in Patients with Schizophrenia", PSYCHIATRY INVESTIGATION, 17(7), pp.695~701 (2020), 대한신경정신의학회[DOI]
- 강은찬, "The Korean Version of the Schizophrenia Cognition Rating Scale: Reliability and Validity", PSYCHIATRY INVESTIGATION, 14(2), pp.141~149 (2017), 대한신경정신의학회[DOI]
- Mazhari S, "Validation of the Persian version of the schizophrenia cognition rating scale (SCoRS) in patients with schizophrenia", Asian J Psychiatr, 27, pp.12~15 (2017)
- Keefe RSE, "Validation of a computerized test of functional capacity", Schizophr Res, 175, pp.90~96 (2016)
- Keefe RS, "Norms and standardization of the brief assessment of cognition in schizophrenia (BACS)", Schizophr Res, 102, pp.108~115 (2008)
- Patterson TL, "UCSD performance-based skills assessment: development of a new measure of everyday functioning for severely mentally ill adults", Schizophr Bull, 27, pp.235~245 (2001)
- McIntosh BJ, "Performance-based assessment of functional skills in severe mental illness:results of a large-scale study in China", J Psychiatr Res, 45, pp.1089~1094 (2011)
- Wang LJ, "Validation of the Chinese version of brief assessment of cognition in schizophrenia", Neuropsychiatr Dis Treat, 12, pp.2819~2826 (2016)
- Wang LJ, "The Chinese version of the brief assessment of cognition in schizophrenia:data of a large-scale mandarin-speaking population", Arch Clin Neuropsychol, 32, pp.289~296 (2017)
- Huang YC, "Defining cognitive and functional profiles in schizophrenia and affective disorders", BMC Psychiatry, 20, pp.39~ (2020)
- Sheehan DV, "The Mini-International Neuropsychiatric Interview (M.I.N.I.):the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10", J Clin Psychiatry, 59(Suppl 20), pp.22~33 (1998)
- American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (1994), American Psychiatric Association
- Keefe RS, "The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery", Schizophr Res, 68, pp.283~297 (2004)
- Mausbach BT, "Development of a brief scale of everyday functioning in persons with serious mental illness", Schizophr Bull, 33, pp.1364~1372 (2007)
- Kay SR, "The positive and negative syndrome scale (PANSS) for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
- Sawamura J, "Is there a linear relationship between the brief psychiatric rating scale and the clinical global impression-schizophrenia scale? A retrospective analysis", BMC Psychiatry, 10, pp.105~ (2010)
- Lane RD, "Assessment of tardive dyskinesia using the abnormal involuntary movement scale", J Nerv Ment Dis, 173, pp.353~357 (1985)
- Simpson GM, "A rating scale for extrapyramidal side effects", Acta Psychiatr Scand Suppl, 212, pp.11~19 (1970)
- Barnes TR, "The Barnes Akathisia rating scale--revisited", J Psychopharmacol, 17, pp.365~370 (2003)
- Mahmood Z, "Neuropsychological predictors of performance-based measures of functional capacity and social skills in individuals with severe mental illness", J Psychiatr Res, 102, pp.201~206 (2018)
- Harvey PD, "Negative symptoms and cognitive deficits: what is the nature of their relationship?", Schizophr Bull, 32, pp.250~258 (2005)
- Monteleone P, "Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the “real-life”", Prog Neuropsychopharmacol Biol Psychiatry, 109, pp.110250~ (2021)
- Fervaha G, "Extrapyramidal symptoms and cognitive test performance in patients with schizophrenia", Schizophr Res, 161, pp.351~356 (2015)
